Abstract Library

#4444 Digestive neuroendocrine tumour diagnosis and therapeutic particularities: Experience of medical oncology centre Annaba, Algeria

Introduction: Neuroendocrine digestive tumours are increasingly diagnosed as a result of the rise in radiological and endoscopic procedures, improved pathological classification, and likely an increase in true incidence. All patient files must be discussed in RCP.

Conference:

Presenting Author:

Authors: Bechairia W, Djedi H,

Keywords: neuroendocrine digestive tumour, late diagnosis, multidisciplinary care,

#4104 Promising outcomes with surufatinib-vinorelbine combination therapy in lung cancer with neuroendocrine differentiation

Introduction: Lung cancer (LC) remains one of the most prevalent and deadly cancers worldwide. Neuroendocrine differentiation (NED) is observed in 25-33% of LC cases. NSCLC patients with NED (NSCLC-NED) often have worse outcomes, resembling SCLC behaviour.

Conference:

Presenting Author:

Authors: Chai M, Zhang Y, Wang Y, Lu Z, Xie J,

Keywords: NSCLC-NED, treatment, surufatinib, vinorelbine,

#3990 Digestive neuroendocine tumors dignosis and therapeutic particularities: Experience of medical oncology center of Annaba, Algeria

Introduction: Digestive neuroendocrine tumors are a specific tumor entity because of its rarity they represent 1% of all digestive tumors and its heterogeneity both clinical and biological.

Conference:

Presenting Author: Bechairia W

Authors: Bechairia W,

Keywords: digestive neuroendocrine tumor, difficult diagnosis, medical treatment, benefit of multidisciplinary care,

#3743 The need of centralisation for small intestinal neuroendocrine tumor surgery – A cohort study from the GTE-Endocan-RENATEN Network, the CentralChirSINET study

Introduction: The concept of surgical centralization is more and more generalized for specific surgical procedure. Small intestinal (SI) neuroendocrine tumor (NET) surgical resection is well standardized and is the cornerstone of the curative care.

Conference:

Presenting Author: Walter T

Authors: Kalifi M, Lardière-Deguelte S, Faron M, Afchain P, de Mestier L,

Keywords: Small intestine, surgery, neuroendocrine tumor, centralization,

#3710 Morphological response on mesenteric mass of small intestinal neuroendocrine tumors treated by 177Lu-DOTATATE: MESENLUTH – A GTE-ENDOCAN study

Introduction: Small intestinal neuroendocrine tumors (SI-NETs) often metastasize, especially to mesenteric lymph nodes, which are frequently affected by fibrosis reactions due to local serotonin secretion. Peptide receptor radionuclide therapy (PRRT) with177Lu-Dotatate has shown its efficacy in the treatment of progressive SI-NETs.

Conference:

Presenting Author: Walter T

Authors: Al Mansour L, de Mestier L, Haissaguerre M, Afchain P, Hadoux J,

Keywords: neuroendocrine tumor, mesenteric mass, objective response, 177Lu-DOTATATE,